Accesso libero

Design, Synthesis and Potential Anti-Proliferative Activity of Some Novel 4-Aminoquinoline Derivatives

INFORMAZIONI SU QUESTO ARTICOLO

Cita

1. V. M. Lakshmi, F. F. Hsu and T. V. Zenser, 2-Nitrosoamino-3-methylimidazo[4,5-f]quinoline stability and reactivity, Chem. Res. Toxicol. 17 (2004) 709-716; DOI: 10.1021/tx030042b.10.1021/tx030042bSearch in Google Scholar

2. M. M. Ghorab, A. M. El-Sherief, Y. A. Ammar and S. I. Mohamed, Synthesis and radiation stability of novel biologically active sulfur compounds derived from 1,2-bis(4-amino-5-mercapto-striazol-3-yl)ethane, Farmaco 55 (2000) 354-361.10.1016/S0014-827X(00)00051-3Search in Google Scholar

3. M. M. Ghorab, F. A. Ragab and M. M. Hamed, Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety, Eur. J. Med. Chem. 44 (2009) 4211-4217; DOI: 10.1016/j.ejmech.2009.05.017.10.1016/j.ejmech.2009.05.01719540022Search in Google Scholar

4. S. Mathan, K. Chandraprakash, C. Uvarani and S. M. Palathurai, Synthesis, antioxidant and toxicological study of novel pyrimido quinoline derivatives from 4-hydroxy-3-acyl quinolin-2-one, Bioorg. Med. Chem. Lett. 20 (2010) 7147-7151; DOI: 10.1016/j.bmcl.2010.09.018.10.1016/j.bmcl.2010.09.01820947350Search in Google Scholar

5. V. G. Brunton, M. J. Lear, P. Mckeown, D. J. Robins and P. Workman, Synthesis and antiproliferative activity of tyrphostins containing quinoline moieties, Anticancer Drug Res. 11 (1996) 463-483.Search in Google Scholar

6. E. W. Chia, A. N. Pearce, M. V. Berridge, L. Larsen, N. B. Perry, C. E. Sansom, C. A. Godfrey, L. R. Hanton, G. L. Lu, M. Walton, W. A. Denny, V. L. Webb, B. R. Copp and J. L. Harper, Synthesis and anti-inflammatory structure-activity relationships of thiazine-quinoline-quinones: Inhibitors of the neutrophil respiratory burst in a model of acute gouty arthritis, Bioorg. Med. Chem. 16 (2008) 9432-9442; DOI: 10.1016/j.bmc.2008.09.052.10.1016/j.bmc.2008.09.05218835721Search in Google Scholar

7. V. R. Solomon and H. Lee, Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies, Eur. J. Pharmacol. 625 (2009) 220-233; DOI: 10.1016/j.ejphar.2009.06.063.10.1016/j.ejphar.2009.06.06319836374Search in Google Scholar

8. I. Perković, S. Tršinar, J. Žanetić, M. Kralj, I. Martin-Kleiner, J. Balzarini, D. Hadjipavlou-Litina, A. M. Katsori and B. Zorc, Novel 1-acyl-4-substituted semicarbazide derivatives of primaquine − synthesis, cytostatic, antiviral and antioxidative studies, J. Enzyme Inhib. Med. Chem. 28 (2013) 601-610; DOI: 10.3109/14756366.2012.663366.10.3109/14756366.2012.66336622380782Search in Google Scholar

9. A. S. Abel, A. D. Averin, O. A. Maloshitskaya, E. N. Savelyev, B. S. Orlinson, I. A. Novakov and I. P. Beletskaya, Palladium-catalyzed amination of dichloroquinolines with adamantane-containg amines, Molecules 18 (2013) 2096-2109; DOI: 10.3390/molecules18022096.10.3390/molecules18022096627035723389254Search in Google Scholar

10. N. Amit, M. Vikramdeep, M. Alpeshkumar, C. Evans and J. Rahul, Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines, Bioorg. Med. Chem. 15 (2007) 626-640; DOI: 10.1016/j.bmc.2006.10.064.10.1016/j.bmc.2006.10.06417107805Search in Google Scholar

11. M. S. Al-Said, M. M. Ghorab and M. Y. Nissan, Dapson in heterocyclic chemistry, part VIII: synthesis, molecular docking and anticancer activity of some novel sulfonylbiscompounds carrying biologically active 1,3-dihydropyridine, chromene and chromenopyridine moieties, Chem. Cent. J. 6 (2012) Article No. 64; DOI: 10.1186/1752-153X-6-64.10.1186/1752-153X-6-64354339122748424Search in Google Scholar

12. M. M. Ghorab, Z. H. Ismail, M. Abdalla and A. A. Radwan, Synthesis, antimicrobial evaluation and molecular modelling of novel sulfonamides carrying a biologically active quinazoline nucleus, Arch. Pharm. Res. 36 (2013) 660-670; DOI: 10.1007/s12272-013-0094-6.10.1007/s12272-013-0094-623529860Search in Google Scholar

13. M. S. Al-Dosari, M. M. Ghorab, M. S. Al-Said and M. Y. Nissan, Discovering some novel 7-chloroquinolines carrying a biologically active benzenesulfonamide moiety as a new class of anticancer agents, Chem. Pharm. Bull. 61 (2013) 50-58; DOI: org/10.1248/cpb.c12-00812.10.1248/cpb.c12-0081223302586Search in Google Scholar

14. M. S. Al-Said, M. S. Bashandy and M. M. Ghorab, Novel quinolines bearing a biologically active trimethoxyphenyl moiety as a new class of antitumor agents, Arzneim. Forsch. 61 (2011) 527-531; DOI: 10.1055/s-0031-1296239.10.1055/s-0031-129623922029230Search in Google Scholar

15. M. S. Bashandy, M. S. Alsaid, S. I. Alqasoumi and M. M. Ghorab, Design and synthesis of some novel hydrazide, 1,2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity, Arzneim. Forsch. 61 (2011) 521-526; DOI: 10.1055/s-0031-1296238.10.1055/s-0031-129623822029229Search in Google Scholar

16. M. M. Ghorab, M. S. Al-Said and E. M. El-Hossary, In vitro cytotoxic evaluation of some new heterocyclic sulfonamide derivatives, J. Heterocycl. Chem. 48 (2011) 563-571; DOI: 10.1002/jhet.619.10.1002/jhet.619Search in Google Scholar

17. M. S. Al-Said, M. S. Bashandy, S. I. Alqasomi and M. M. Ghorab, Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives, Eur. J. Med. Chem. 46 (2011) 137-141; DOI: 10.1016/j.ejmech.2010.10.024.10.1016/j.ejmech.2010.10.02421093116Search in Google Scholar

18 M. M. Ghorab, F. A. Ragab, H. I. Heiba, R. K. Arafa and E. M. El-Hossary, Docking study, in vitro anticancer screening and radiosensitizing evaluation of some new fluorine-containing quinoline and pyrimidoquinoline derivatives bearing a sulfonamide moiety, Med. Chem. Res. 20 (2011) 388-400; DOI: 10.1007/s00044-010-9332-3.10.1007/s00044-010-9332-3Search in Google Scholar

19. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst. 82 (1990) 1107-1112; DOI: 10.1093/jnci/82.13.1107. 10.1093/jnci/82.13.11072359136Search in Google Scholar

eISSN:
1846-9558
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Pharmacy, other